Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World ...

Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

Fluorescence navigation is a novel technique for accurately identifying hepatocellular carcinoma (HCC) lesions during hepatectomy, enabling real-time visualization. Indocyanine green-based ...

A retrospective study including patients with advanced hepatocellular carcinoma (HCC) who received first-line atezolizumab plus bevacizumab (ate + bev) at 4 centers in Taiwan showed promising ...

This Series explores three key areas in the modern management of hepatocellular carcinoma. The first paper examines the personalisation of surgery for patients with hepatocellular carcinoma, which ...

A robot upgrade is transforming cancer surgery in South Carolina. The Da Vinci SP made its way to the operating room for doctors at Trident Medical Center. The robot that uses a single port, or one ...

Out of the 16 patients in the study, half had a strong response to the vaccine. A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a ...

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates. It arises from chronic liver diseases, including hepatitis B or C infections, ...

Given the potential for both excessive and inadequate immunosuppression to adversely affect patients with recurrent hepatocellular carcinoma post-liver transplantation ... This suggests that while ...